Trials24 News

Dr. Tobias Kruse showcased Trials24’s patient recruitment strategies utilizing social media platforms such as TikTok, Instagram, and Facebook.

Trials24 exhibited at the BIO International Convention, hosted multiple meetings, and participated in an event held by BIO.NRW.

Trials24 recently showcased innovative ways to leverage Google, Facebook, Instagram, and TikTok for patient recruitment at the DGPharMed event.

Dr. Tobias Kruse recently participated in TransPerfect Life Sciences’ #C3SummitLondon on May 2, 2024. The summit featured discussions on the latest practices in clinical trials, focusing on patient recruitment and retention.

This gathering allowed Trials24 to attend partnering meetings and showcase how online patient recruitment is shortening clinical trial timelines.

Trials24 participated in the 19th Munich AIDS and Infection Days, where Ann-Katrin Rueß, Global Patient Recruitment Manager, shared insights on digital strategies for recruiting clinical trial participants.

Showcasing Trials24’s solutions for effective online patient recruitment management

Trials24’s founder and TUM alumni, Dr. Tobias Kruse, shared valuable insights at Venture Labs’ Discussion on Entrepreneurship in Digital Health at the Technical University of Munich.

Trials24 reflects on key discussions and connections made at the Biotech Showcase & JPM 2024.

Trials24 took part in Nordic Life Science Days 2023, an event in the life science industry in Copenhagen on November 29-30.

On November 23, 2023, in Munich, Germany, our team immersed itself in the enriching atmosphere of the 31st BVMA Symposium organized by the German Federal Association of Contract Research Organizations.

Our company participates in Munich’s prestigious BIO-Europe partnering conference from November 6-8, 2023.

We are pleased to share our experience at the recent “KI in der Klinischen Forschung” (AI in Clinical Research) event organized by DGPharMed e.V. on October 25th, 2023, in Munich.

“Every challenge in clinical trials is an opportunity for innovation,” – Dr. Tobias Kruse.

Our CEO, Dr. Tobias Kruse, and our Business Development Director, Dr. Matthias Roos, participated in the Clinical Research Committee of Bundesverband der Pharmazeutischen Industrie.

Trials24’s CEO, Dr. Tobias Kruse, and Dr. Ulrich Granzer collaborated at an MNG Lecture Event, discussing “New Treatment Modalities: Regulatory Implications and Patient Recruitment.”

Trials24 participated in the 13th Operational Excellence In Clinical Trials Summit on the 8th-9th of March 2023, in Berlin, organized by KP Morgan.

With Dr. Andrea Röthler, Head of Project Management, GKM (Gesellschaft für Therapieforschung mbH), and our CEO, Dr. Tobias Kruse, we have explored decentralized approaches for patient recruitment, emphasizing the importance of interactive engagement for sponsors seeking effective solutions.

The event featured discussions on decentralized clinical trials and the integration of real-world data (RWD) in research.

In our interview with Alcedis, we focused on Trials24’s innovative methods in patient recruitment for clinical trials, highlighting digital approaches to connect with potential participants who are typically hard to reach through traditional methods.

In his keynote speech, Dr. Tobias Kruse highlighted a significant obstacle in clinical trials: patient recruitment.